Biozoom (OTC:BIZM) is a "development stage" company whose "plan of operation" does not involve generating any future revenue. The firm's only source of "net income" was from the "extinguishing of debt," and it is my belief that the current market capitalization of $234.14M is completely unwarranted in light of the fact that there is no underlying business, and I further believe that shares have simply been bid up due to a press release in which it touted the use of the "Biozoom scanner" was found - by Charite University Hospital Berlin - to lead to youth making "healthier choices" after using the scanner.
With the press release dubious and the underlying business non-existent, shares of Biozoom are...
Only subscribers can access this article, which is part of the PRO research library covering 3,575 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: